Concepts (275)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colonic Neoplasms | 20 | 1996 | 254 | 1.040 |
Why?
|
| Cell Nucleus | 18 | 1992 | 679 | 0.470 |
Why?
|
| Transforming Growth Factor alpha | 4 | 1993 | 27 | 0.340 |
Why?
|
| Pharmacopoeias as Topic | 2 | 2006 | 4 | 0.330 |
Why?
|
| Antigens, Neoplasm | 9 | 1989 | 394 | 0.310 |
Why?
|
| Adenocarcinoma | 7 | 1996 | 1009 | 0.300 |
Why?
|
| ErbB Receptors | 5 | 1993 | 282 | 0.300 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 20 | 1992 | 314 | 0.280 |
Why?
|
| Neoplasm Proteins | 13 | 1988 | 675 | 0.270 |
Why?
|
| Epidermal Growth Factor | 5 | 1996 | 122 | 0.240 |
Why?
|
| Advisory Committees | 1 | 2006 | 148 | 0.240 |
Why?
|
| Tumor Cells, Cultured | 11 | 1996 | 1076 | 0.220 |
Why?
|
| Chromatin | 17 | 1986 | 551 | 0.220 |
Why?
|
| Cytosol | 7 | 1988 | 160 | 0.210 |
Why?
|
| Nucleoproteins | 10 | 1983 | 26 | 0.200 |
Why?
|
| Molecular Weight | 20 | 1989 | 393 | 0.180 |
Why?
|
| Chromosomal Proteins, Non-Histone | 6 | 1986 | 214 | 0.180 |
Why?
|
| Cell Nucleolus | 12 | 1987 | 56 | 0.170 |
Why?
|
| Allied Health Occupations | 1 | 1998 | 4 | 0.160 |
Why?
|
| Liver | 18 | 1987 | 1858 | 0.150 |
Why?
|
| Glutathione Transferase | 3 | 1987 | 153 | 0.150 |
Why?
|
| Problem-Based Learning | 1 | 1998 | 68 | 0.150 |
Why?
|
| Carcinoma | 3 | 1991 | 282 | 0.140 |
Why?
|
| Education, Medical, Undergraduate | 1 | 1998 | 166 | 0.130 |
Why?
|
| Transferrin | 1 | 1996 | 51 | 0.130 |
Why?
|
| Rats | 30 | 1987 | 3663 | 0.130 |
Why?
|
| Liver Neoplasms, Experimental | 8 | 1987 | 66 | 0.130 |
Why?
|
| Antigens | 4 | 1985 | 156 | 0.120 |
Why?
|
| Pharmaceutical Preparations | 2 | 2006 | 80 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 3 | 1991 | 1022 | 0.120 |
Why?
|
| Cell Line | 13 | 1992 | 2787 | 0.110 |
Why?
|
| Insulin | 2 | 1996 | 1186 | 0.110 |
Why?
|
| 2-Chloroadenosine | 1 | 1992 | 6 | 0.110 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1992 | 24 | 0.110 |
Why?
|
| DNA, Neoplasm | 3 | 1993 | 303 | 0.100 |
Why?
|
| Cell Division | 7 | 1993 | 795 | 0.100 |
Why?
|
| Prodrugs | 1 | 1992 | 59 | 0.100 |
Why?
|
| Gene Amplification | 1 | 1993 | 228 | 0.100 |
Why?
|
| DNA, Antisense | 1 | 1992 | 8 | 0.100 |
Why?
|
| Phosphatidylethanolamines | 1 | 1992 | 22 | 0.100 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1992 | 54 | 0.100 |
Why?
|
| Fibroblast Growth Factors | 1 | 1993 | 154 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 13 | 1978 | 957 | 0.100 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1992 | 74 | 0.100 |
Why?
|
| Silver | 2 | 1988 | 22 | 0.090 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 1991 | 44 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1992 | 187 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 7 | 1988 | 462 | 0.090 |
Why?
|
| Proteins | 4 | 1988 | 1042 | 0.090 |
Why?
|
| Mitomycins | 3 | 1986 | 10 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 1992 | 471 | 0.080 |
Why?
|
| Ribonucleoproteins | 4 | 1986 | 63 | 0.080 |
Why?
|
| Immunosorbent Techniques | 2 | 1988 | 26 | 0.080 |
Why?
|
| Liver Regeneration | 5 | 1987 | 52 | 0.080 |
Why?
|
| Neoplasms, Experimental | 13 | 1978 | 215 | 0.080 |
Why?
|
| Carcinoma 256, Walker | 5 | 1976 | 5 | 0.080 |
Why?
|
| Animals | 44 | 1993 | 33898 | 0.080 |
Why?
|
| Reference Standards | 2 | 2006 | 239 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 1992 | 1355 | 0.070 |
Why?
|
| Amino Acids | 13 | 1986 | 661 | 0.070 |
Why?
|
| Liver Neoplasms | 14 | 1978 | 1387 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 1993 | 561 | 0.070 |
Why?
|
| Immunoenzyme Techniques | 5 | 1988 | 268 | 0.070 |
Why?
|
| Isoenzymes | 1 | 1987 | 223 | 0.070 |
Why?
|
| Colon | 1 | 1989 | 355 | 0.070 |
Why?
|
| Phosphoproteins | 2 | 1985 | 401 | 0.070 |
Why?
|
| Societies, Pharmaceutical | 1 | 2006 | 11 | 0.070 |
Why?
|
| Dosage Forms | 1 | 2005 | 9 | 0.070 |
Why?
|
| Antibodies | 3 | 1984 | 371 | 0.060 |
Why?
|
| Immunoelectrophoresis | 4 | 1981 | 11 | 0.060 |
Why?
|
| Isoelectric Point | 4 | 1988 | 18 | 0.060 |
Why?
|
| Phosphorylation | 3 | 1993 | 1615 | 0.060 |
Why?
|
| Microfilament Proteins | 1 | 1986 | 278 | 0.060 |
Why?
|
| Humans | 29 | 2006 | 122412 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 1986 | 1023 | 0.050 |
Why?
|
| Receptors, Fibroblast Growth Factor | 2 | 1993 | 60 | 0.050 |
Why?
|
| Peptide Fragments | 7 | 1986 | 745 | 0.050 |
Why?
|
| DNA | 5 | 1986 | 1608 | 0.050 |
Why?
|
| Drug Resistance | 4 | 1992 | 257 | 0.050 |
Why?
|
| Horseradish Peroxidase | 1 | 1980 | 14 | 0.050 |
Why?
|
| Peroxidases | 1 | 1980 | 26 | 0.050 |
Why?
|
| Cytoplasm | 2 | 1979 | 291 | 0.050 |
Why?
|
| Muscles | 1 | 1981 | 289 | 0.040 |
Why?
|
| Heme | 1 | 1980 | 53 | 0.040 |
Why?
|
| Histones | 8 | 1976 | 528 | 0.040 |
Why?
|
| Microscopy, Electron | 7 | 1987 | 401 | 0.040 |
Why?
|
| Cell Differentiation | 4 | 1996 | 1935 | 0.040 |
Why?
|
| Blotting, Western | 2 | 1993 | 1106 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 1988 | 1431 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1993 | 631 | 0.040 |
Why?
|
| Trypsin | 6 | 1986 | 95 | 0.040 |
Why?
|
| Kinetics | 3 | 1992 | 1318 | 0.040 |
Why?
|
| Actins | 1 | 1981 | 342 | 0.040 |
Why?
|
| Thymus Gland | 4 | 1975 | 101 | 0.040 |
Why?
|
| DNA Helicases | 1 | 1979 | 225 | 0.040 |
Why?
|
| Lymphocytes | 2 | 1978 | 404 | 0.040 |
Why?
|
| Problem Solving | 1 | 1998 | 63 | 0.040 |
Why?
|
| Staining and Labeling | 3 | 1988 | 186 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 1978 | 681 | 0.040 |
Why?
|
| Precipitin Tests | 2 | 1993 | 153 | 0.030 |
Why?
|
| Leukemia, Lymphoid | 1 | 1976 | 108 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 1993 | 260 | 0.030 |
Why?
|
| Culture Media, Serum-Free | 1 | 1996 | 22 | 0.030 |
Why?
|
| Ascites | 2 | 1973 | 88 | 0.030 |
Why?
|
| Microinjections | 2 | 1987 | 53 | 0.030 |
Why?
|
| Amino Acid Sequence | 7 | 1985 | 2700 | 0.030 |
Why?
|
| Arginine | 4 | 1985 | 303 | 0.030 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 2 | 1986 | 17 | 0.030 |
Why?
|
| Drug Synergism | 1 | 1996 | 233 | 0.030 |
Why?
|
| Isoelectric Focusing | 2 | 1988 | 24 | 0.030 |
Why?
|
| Biotransformation | 2 | 1992 | 49 | 0.030 |
Why?
|
| Rabbits | 4 | 1983 | 716 | 0.030 |
Why?
|
| United States | 2 | 2006 | 10475 | 0.030 |
Why?
|
| Acetamides | 1 | 1974 | 49 | 0.030 |
Why?
|
| Pancreatic Elastase | 1 | 1993 | 13 | 0.030 |
Why?
|
| Peptides | 5 | 1985 | 801 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1993 | 217 | 0.030 |
Why?
|
| Cell Count | 1 | 1993 | 253 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 1992 | 96 | 0.030 |
Why?
|
| Rectal Neoplasms | 1 | 1993 | 76 | 0.030 |
Why?
|
| Dimethylformamide | 1 | 1992 | 3 | 0.030 |
Why?
|
| Cricetinae | 2 | 1983 | 411 | 0.030 |
Why?
|
| Butyric Acid | 1 | 1992 | 7 | 0.030 |
Why?
|
| Blood | 1 | 1992 | 105 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1992 | 83 | 0.020 |
Why?
|
| Culture Media | 1 | 1992 | 183 | 0.020 |
Why?
|
| Butyrates | 1 | 1992 | 35 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1992 | 339 | 0.020 |
Why?
|
| Tretinoin | 1 | 1992 | 117 | 0.020 |
Why?
|
| RNA | 3 | 1985 | 577 | 0.020 |
Why?
|
| Down-Regulation | 1 | 1993 | 701 | 0.020 |
Why?
|
| Biological Transport | 1 | 1992 | 347 | 0.020 |
Why?
|
| Mitomycin | 3 | 1986 | 50 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1993 | 670 | 0.020 |
Why?
|
| Erythrocytes | 2 | 1983 | 207 | 0.020 |
Why?
|
| Ligands | 1 | 1992 | 538 | 0.020 |
Why?
|
| Up-Regulation | 1 | 1993 | 872 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1991 | 213 | 0.020 |
Why?
|
| Sulfuric Acids | 3 | 1974 | 6 | 0.020 |
Why?
|
| Transfection | 1 | 1992 | 1076 | 0.020 |
Why?
|
| Texas | 1 | 1998 | 3508 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1993 | 1403 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 1992 | 459 | 0.020 |
Why?
|
| Collodion | 1 | 1988 | 8 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 1987 | 98 | 0.020 |
Why?
|
| Interferons | 1 | 1988 | 120 | 0.020 |
Why?
|
| Base Sequence | 1 | 1992 | 3119 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1991 | 1678 | 0.020 |
Why?
|
| Nuclear Proteins | 2 | 1985 | 1283 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1989 | 815 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 3887 | 0.020 |
Why?
|
| Gelsolin | 1 | 1986 | 13 | 0.020 |
Why?
|
| Methods | 4 | 1974 | 149 | 0.020 |
Why?
|
| Antibody Specificity | 2 | 1983 | 204 | 0.020 |
Why?
|
| Therapeutic Equivalency | 1 | 2005 | 13 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 1986 | 42 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2005 | 44 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1986 | 186 | 0.020 |
Why?
|
| Autoradiography | 1 | 1985 | 71 | 0.020 |
Why?
|
| Melanoma | 1 | 1993 | 836 | 0.020 |
Why?
|
| Chromatography, Gel | 5 | 1985 | 96 | 0.020 |
Why?
|
| Biotechnology | 1 | 2005 | 55 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 1988 | 1009 | 0.020 |
Why?
|
| snRNP Core Proteins | 1 | 1985 | 8 | 0.020 |
Why?
|
| Epitopes | 2 | 1985 | 429 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 1985 | 39 | 0.020 |
Why?
|
| Deoxyribonuclease I | 1 | 1985 | 50 | 0.020 |
Why?
|
| Ribonucleases | 1 | 1985 | 55 | 0.020 |
Why?
|
| Glycoproteins | 2 | 1978 | 371 | 0.020 |
Why?
|
| Thioacetamide | 2 | 1975 | 3 | 0.020 |
Why?
|
| Glycine | 1 | 1985 | 167 | 0.010 |
Why?
|
| Scleroderma, Systemic | 1 | 1985 | 117 | 0.010 |
Why?
|
| Autoantigens | 1 | 1985 | 132 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1992 | 1890 | 0.010 |
Why?
|
| Mice | 4 | 1988 | 17638 | 0.010 |
Why?
|
| Phenotype | 2 | 1993 | 4217 | 0.010 |
Why?
|
| Immunoelectrophoresis, Two-Dimensional | 1 | 1983 | 2 | 0.010 |
Why?
|
| Histological Techniques | 2 | 1973 | 21 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1983 | 109 | 0.010 |
Why?
|
| Immune Sera | 1 | 1983 | 95 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1983 | 21 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1983 | 71 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 1982 | 82 | 0.010 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1983 | 245 | 0.010 |
Why?
|
| Cattle | 5 | 1975 | 559 | 0.010 |
Why?
|
| Lectins | 2 | 1978 | 48 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1987 | 3076 | 0.010 |
Why?
|
| Protein Conformation | 2 | 1982 | 835 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1984 | 619 | 0.010 |
Why?
|
| Ampholyte Mixtures | 1 | 1981 | 1 | 0.010 |
Why?
|
| Affinity Labels | 1 | 1980 | 14 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1993 | 2480 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1981 | 192 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1981 | 427 | 0.010 |
Why?
|
| Citrates | 3 | 1975 | 21 | 0.010 |
Why?
|
| Heterochromatin | 1 | 1979 | 48 | 0.010 |
Why?
|
| RNA, Neoplasm | 2 | 1977 | 138 | 0.010 |
Why?
|
| Nuclear Envelope | 1 | 1979 | 17 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 1978 | 16 | 0.010 |
Why?
|
| Thermolysin | 3 | 1972 | 4 | 0.010 |
Why?
|
| Binding Sites | 1 | 1980 | 1298 | 0.010 |
Why?
|
| Protein Binding | 1 | 1982 | 1740 | 0.010 |
Why?
|
| Neoplasm Transplantation | 3 | 1986 | 375 | 0.010 |
Why?
|
| Microsomes | 1 | 1976 | 56 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1978 | 808 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1976 | 86 | 0.010 |
Why?
|
| Male | 11 | 1981 | 59581 | 0.010 |
Why?
|
| Maleates | 2 | 1972 | 14 | 0.010 |
Why?
|
| Electrophoresis, Paper | 2 | 1972 | 3 | 0.010 |
Why?
|
| Pepsin A | 2 | 1972 | 12 | 0.010 |
Why?
|
| Chymotrypsin | 2 | 1972 | 16 | 0.010 |
Why?
|
| In Vitro Techniques | 2 | 1977 | 968 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 2 | 1972 | 68 | 0.010 |
Why?
|
| Time Factors | 3 | 1993 | 6176 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1975 | 38 | 0.010 |
Why?
|
| Chromosomes | 1 | 1975 | 199 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 1976 | 261 | 0.010 |
Why?
|
| Bone Marrow | 1 | 1976 | 319 | 0.010 |
Why?
|
| Structure-Activity Relationship | 2 | 1986 | 571 | 0.010 |
Why?
|
| Transplantation, Heterologous | 2 | 1986 | 257 | 0.010 |
Why?
|
| Hepatectomy | 1 | 1975 | 122 | 0.010 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1993 | 14 | 0.010 |
Why?
|
| Mucin-1 | 1 | 1993 | 35 | 0.010 |
Why?
|
| Deoxyribonucleases | 1 | 1973 | 26 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1993 | 75 | 0.010 |
Why?
|
| Growth Substances | 2 | 1984 | 113 | 0.010 |
Why?
|
| Histocytochemistry | 2 | 1985 | 106 | 0.010 |
Why?
|
| Mucins | 1 | 1993 | 74 | 0.010 |
Why?
|
| Dansyl Compounds | 1 | 1972 | 3 | 0.010 |
Why?
|
| Thiocyanates | 1 | 1972 | 10 | 0.010 |
Why?
|
| Ribonucleosides | 1 | 1972 | 15 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1972 | 21 | 0.010 |
Why?
|
| Genetic Code | 1 | 1972 | 40 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1972 | 106 | 0.010 |
Why?
|
| RNA, Ribosomal | 1 | 1972 | 58 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1972 | 86 | 0.010 |
Why?
|
| Ribonucleotides | 1 | 1972 | 36 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 1993 | 414 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1979 | 1527 | 0.010 |
Why?
|
| Immunodiffusion | 2 | 1979 | 22 | 0.010 |
Why?
|
| Kidney | 1 | 1975 | 1345 | 0.000 |
Why?
|
| Physarum | 1 | 1985 | 1 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1985 | 11 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 1 | 1987 | 331 | 0.000 |
Why?
|
| Transforming Growth Factors | 1 | 1985 | 20 | 0.000 |
Why?
|
| Chemistry | 2 | 1977 | 59 | 0.000 |
Why?
|
| Chemical Phenomena | 2 | 1977 | 84 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1972 | 2833 | 0.000 |
Why?
|
| Sucrose | 2 | 1975 | 40 | 0.000 |
Why?
|
| Drug Stability | 1 | 1984 | 55 | 0.000 |
Why?
|
| Ascitic Fluid | 1 | 1984 | 31 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1984 | 135 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 2 | 1974 | 256 | 0.000 |
Why?
|
| Clone Cells | 1 | 1984 | 167 | 0.000 |
Why?
|
| Autoantibodies | 1 | 1985 | 420 | 0.000 |
Why?
|
| Methylation | 1 | 1982 | 227 | 0.000 |
Why?
|
| Mice, Nude | 1 | 1984 | 697 | 0.000 |
Why?
|
| Cell Survival | 1 | 1984 | 817 | 0.000 |
Why?
|
| Periodic Acid-Schiff Reaction | 1 | 1978 | 3 | 0.000 |
Why?
|
| Electrophoresis | 1 | 1978 | 46 | 0.000 |
Why?
|
| Chickens | 1 | 1979 | 637 | 0.000 |
Why?
|
| RNA Polymerase I | 1 | 1977 | 11 | 0.000 |
Why?
|
| Poly A | 1 | 1976 | 59 | 0.000 |
Why?
|
| Culture Techniques | 1 | 1975 | 91 | 0.000 |
Why?
|
| Fetus | 1 | 1978 | 579 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1984 | 1680 | 0.000 |
Why?
|
| Acrylamides | 1 | 1974 | 18 | 0.000 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1973 | 97 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1976 | 668 | 0.000 |
Why?
|
| Acylation | 1 | 1972 | 16 | 0.000 |
Why?
|
| Carboxypeptidases | 1 | 1972 | 16 | 0.000 |
Why?
|
| Hydrolysis | 1 | 1972 | 156 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1977 | 981 | 0.000 |
Why?
|
| Lysine | 1 | 1972 | 201 | 0.000 |
Why?
|
| Aging | 1 | 1978 | 1163 | 0.000 |
Why?
|